A-share innovative drug concept stocks fluctuated and strengthened, Borrui Pharmaceutical rose by more than 10%, hitting a four-year high, Edi Pharmaceuticals and Kangchen Pharmaceuticals rose by more than 6%, and Northland, Baili Tianheng, Rongchang Biopharma, Junshi Biopharma and others were among the top gainers.